|
1
|
Picci P: Osteosarcoma (osteogenic
sarcoma). Orphanet J Rare Dis. 2:62007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Heare T, Hensley MA and Dell'Orfano S:
Bone tumors: Osteosarcoma and Ewing's sarcoma. Curr Opin Pediatr.
21:365–372. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Weeden S, Grimer RJ, Cannon SR, Taminiau
AH and Uscinska BM; European Osteosarcoma Intergroup: The effect of
local recurrence on survival in resected osteosarcoma. Eur J
Cancer. 37:39–46. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hu J, Li X, Guo X, Guo Q, Xiang C, Zhang
Z, Xing Y, Xi T and Zheng L: CCR2 3′UTR functions as a competing
endogenous RNA to inhibit breast cancer metastasis. J Cell Sci.
130:3399–3413. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nahas GR, Murthy RG, Patel SA, Ganta T,
Greco SJ and Rameshwar P: The RNA-binding protein Musashi 1
stabilizes the oncotachykinin 1 mRNA in breast cancer cells to
promote cell growth. FASEB J. 30:149–159. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Fang L, Du WW, Yang X, Chen K, Ghanekar A,
Levy G, Yang W, Yee AJ, Lu WY, Xuan JW, et al: Versican
3′-untranslated region (3′-UTR) functions as a ceRNA in inducing
the development of hepatocellular carcinoma by regulating miRNA
activity. FASEB J. 27:907–919. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang W, Vreeland AC and Noy N:
RNA-binding protein HuR regulates nuclear import of protein. J Cell
Sci. 129:4025–4033. 2016.PubMed/NCBI
|
|
8
|
Steinmeyer N, Doller A, Biyanee A, Brauss
T, Schmid T, Pfeilschifter J and Eberhardt W: Lymphotoxin α, a
novel target of posttranscriptional gene regulation by HuR in HepG2
cells. FEBS Lett. 589:1943–1950. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Xu G, Wang J, Jia Y, Shen F, Han W and
Kang Y: MiR-142-3p functions as a potential tumor suppressor in
human osteosarcoma by targeting HMGA1. Cell Physiol Biochem.
33:1329–1339. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu K, Huang J, Ni J, Song D, Ding M, Wang
J, Huang X and Li W: MALAT1 promotes osteosarcoma development by
regulation of HMGB1 via miR-142-3p and miR-129-5p. Cell Cycle.
16:578–587. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhong J, Liu C, Zhang QH, Chen L, Shen YY,
Chen YJ, Zeng X, Zu XY and Cao RX: TGF-β1 induces HMGA1 expression:
The role of HMGA1 in thyroid cancer proliferation and invasion. Int
J Oncol. 50:1567–1578. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang Q, Wang X, Tang C, Chen X and He J:
H19 promotes the migration and invasion of colon cancer by sponging
miR-138 to upregulate the expression of HMGA1. Int J Oncol.
50:1567–1578. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Livak KJ and Scmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Romeo C, Weber MC, Zarei M, DeCicco D,
Chand SN, Lobo AD, Winter JM, Sawicki JA, Sachs JN, Meisner-Kober
N, et al: HuR contributes to TRAIL resistance by restricting death
receptor 4 expression in pancreatic cancer cells. Mol Cancer Res.
14:599–611. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Muralidharan R, Panneerselvam J, Chen A,
Zhao YD, Munshi A and Ramesh R: HuR-targeted nanotherapy in
combination with AMD3100 suppresses CXCR4 expression, cell growth,
migration and invasion in lung cancer. Cancer Gene Ther.
22:581–590. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kuwano Y, Nishida K, Kajita K, Satake Y,
Akaike Y, Fujita K, Kano S, Masuda K and Rokutan K: Transformer 2β
and miR-204 regulate apoptosis through competitive binding to 3′
UTR of BCL2 mRNA. Cell Death Differ. 22:815–825. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cheng F, Pan Y, Lu YM, Zhu L and Chen S:
RNA-binding protein Dnd1 promotes breast cancer apoptosis by
stabilizing the Bim mRNA in a miR-221 binding site. Biomed Res Int.
2017:95961522017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Conte A, Paladino S, Bianco G, Fasano D,
Gerlini R, Tornincasa M, Renna M, Fusco A, Tramontano D and
Pierantoni GM: High mobility group A1 protein modulates autophagy
in cancer cells. Cell Death Differ. 24:1948–1962. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Dai N, Ji F, Wright J, Minichiello L,
Sadreyev R and Avruch J: IGF2 mRNA binding protein-2 is a tumor
promoter that drives cancer proliferation through its client mRNAs
IGF2 and HMGA1. Elife. 6:e271552017. View Article : Google Scholar : PubMed/NCBI
|
